
Delhi is preparing to ensure to not get caught off-guard if a third wave of coronavirus hits the capital.
India added 1.14 lakh new coronavirus cases over the last 24 hours while deaths from COVID-19 rose by 2,667.The country's overall case load now stands at 2.88 crore, while total fatalities are at 3.46 lakh, according to the health ministry.
About 20 lakh tests were conducted on Saturday taking the total cumulative tests conducted so far to 36,47,46,522, while the daily positivity has further declined to 5.62 per cent . It has been less than 10 per cent for 13 consecutive days, the ministry said.
Meanwhile, Delhi is preparing well to ensure to not get caught off-guard if a third wave of coronavirus hits the capital, Chief Minister Arvind Kejriwal said in a presser where he also announced Unlock guidelines. Announcing steps to tackle the pandemic, Mr Kejriwal laid out his government's plans.
Maharashtra, which is under a strict lockdown to contain the massive coronavirus crisis in the state, will be unlocking from Monday in five phases based on positivity rate occupancy of oxygen beds.
A company in Malta has expressed interest to supply up to 60 million doses of the Russian vaccine Sputnik V to Haryana directly, the state government said today. Pharma Regulatory Services Ltd, whose headquarters is in the European nation, has given an "expression of Interest" but did not bid for a contract yet, the state government said in a statement. The foreign company offered to sell the vaccine at ₹ 1,120 per dose.
Here are the Live Updates on Coronavirus:
A company in Malta has expressed interest to supply up to 60 million doses of the Russian vaccine Sputnik V to Haryana directly, the state government said on Saturday. Pharma Regulatory Services Ltd, whose headquarters is in the European nation, has given an "expression of Interest" but did not bid for a contract yet, the state government said in a statement.
The foreign company offered to sell the vaccine at Rs 1,120 per dose.

The centre on Saturday defended its liberalised vaccine policy and said the media reports suggesting inequities in distribution of doses were "inaccurate and speculative in nature".